$GEL

ALBERT CONRAD P sold (to issuer) $37K of GEL

ALBERT CONRAD P sold (to issuer) 2,500 shares of GENESIS ENERGY LP (GEL) at $14.77 on 2026-07-01.

Original reporting
SEC EDGAR · ALBERT CONRAD P
Published Jul 2, 2026, 9:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 2, 2026, 9:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$GEL
Neutral
medium confidence
Mentioned
$GEL
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GELNeutralLow
01

Why it matters

The newest disclosed fact is the specific sale: 2,500 shares at $14.7700 on 2026-07-01, leaving 15,000 shares. No 10b5-1 plan is indicated.

02

Market read

This provides incremental insider-trading data for GEL but is unlikely to drive a major repricing given the small transaction size and issuer-sale code.

03

What to watch

The transaction code is “sale to issuer,” which often corresponds to issuer buyback mechanics; without context on the buyback program, directional inference is weak.

Relevance 3/10Novelty 3/10Timing: Filed 2026-07-02; transaction dated 2026-07-01.

Background

The filing is an SEC Form 4 insider transaction for Genesis Energy LP (GEL) by director Albert Conrad P.

Company-level read

Ticker impact

$GELNeutralMedium confidence
Context

Genesis Energy LP director Albert Conrad P sold 2,500 shares to the issuer at $14.7700 on 2026-07-01, per Form 4.

Expected impact

Minimal immediate price impact; watch for follow-on insider activity or unusual volume around future buyback/insider filings.

Evidence & confidence

Form 4 shows a small, director-level transaction (total ~$36.9k) and explicitly notes no pre-arranged 10b5-1 plan, but the transaction code indicates sale to issuer, which is often mechanical and not a strong directional catalyst.

Market effects

No sector read-through; this is a single-company insider transaction with small dollar value.

None indicated.

None indicated.

Counterpoint

Absence of a 10b5-1 plan could be interpreted as less “scheduled” selling, so some traders may treat it as a mild negative signal despite the small size.

Key entities

  • GENESIS ENERGY LP

    Subject of the Form 4 insider transaction; director sold shares to the issuer.

  • ALBERT CONRAD P

    Director who sold 2,500 shares to the issuer at $14.7700 per share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$KMIMedAI 8/10

Q2 Earnings Roundup: Kinder Morgan (NYSE:KMI) And The Rest Of The Infrastructure Segment

Kinder Morgan (KMI) and other infrastructure stocks reported strong Q2 earnings, with revenues up 14.1% on average. KMI's revenue rose 10.8% YoY, beating estimates. Genesis Energy (GEL) saw a 41% revenue increase, while DHT Holdings (DHT) had 174% growth. Expand Energy (EXE) and Kodiak Gas Services (KGS) also reported, with mixed results. Stocks in the sector are up 9.2% on average since earnings.

$GELMed

Oil, hunters, and Dr. Phil: How a longshot project is shaking up Greenland

The New York Times reports Greenland Energy Co. is seeking approval to drill exploratory wells at Jameson Land, Greenland, after a June community meeting drew criticism over profit sharing and environmental impacts. Greenland authorities pushed final approvals back to unlikely before 2028, and Greenland Energy shifted to one well. Its shares fell to about $1. The project is backed by Dr. Phil and Gov. Jeff Landry, with documents reviewed by the Times citing a pre-policy-change license.

$GELMed

Genesis Energy Q2 Earnings Call Highlights

Genesis Energy (NYSE:GEL) said it reduced borrowings on its $900 million senior secured credit facility to zero and retired about $218 million of Series A preferred securities in 1H 2026. It issued $750 million 6.75% notes due 2034 and redeemed 7.75% notes due 2028, targeting ~$25 million lower annualized all-in cost of capital. Quarterly distribution rose to $0.20.

$GELMed

Genesis Energy (NYSE:GEL) Delivers Strong Q2 CY2026 Numbers

Genesis Energy (NYSE:GEL) reported Q2 2026 results. Revenue rose 41% year on year to $532 million, beating Wall Street estimates by 26.2%, and GAAP profit was $0.26 per share above consensus. The article also cites adjusted EBITDA margin of 32.2% and free cash flow margin averaging -2.8% over five years, with shares up 2.4% to $15.21 after the release.

$GELMedAI 8/10

GENESIS ENERGY LP (GEL): Results of Operations and Financial Condition

GENESIS ENERGY LP (GEL) filed an SEC Form 8-K — Results of Operations and Financial Condition. FOR IMMEDIATE RELEASE August 6, 2026 Genesis Energy, L.P. Reports Second Quarter 2026 Results HOUSTON – (BUSINESS WIRE) – Genesis Energy, L.P. (NYSE: GEL) today announced its second quarter results. We generated the following financial results for the second quarter of 2026: • Ne